Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.
Research and practice in thrombosis and haemostasis
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationLung cancer (Amsterdam, Netherlands)
View this publicationRheumatology (Oxford, England)
View this publicationNature immunology
View this publicationClinical research in cardiology : official journal of the German Cardiac Society
View this publicationbioRxiv : the preprint server for biology
View this publicationHepatology communications
View this publicationMechanisms of ageing and development
View this publicationJournal of neurology
View this publicationNature immunology
View this publication